Research overview
What is P21 (P021)?
Peptide 021 (P021) was designed from a ciliary neurotrophic factor-derived short sequence and further modified with an adamantylated glycine moiety. The exact experimental construct matters; a simple catalog abbreviation does not establish identity or product equivalence.
What has research examined?
An original 3xTg-AD mouse study examined prolonged dietary P021 exposure before overt pathology and measured synaptic markers and cognitive tasks. A separate developmental mouse study investigated prenatal-to-postnatal exposure. Neither design establishes a dementia treatment or preventive strategy in humans.
Mouse-model cognition, timing, and delivery cannot be transferred to people or independent vials. No amount, preparation, or use is recommended.
Research references
- P021 prevention of synaptic deficits in transgenic Alzheimer-model miceAlzheimer’s Research & Therapy; mouse study
- P021 in a Ts65Dn developmental mouse modelPreclinical research
Calculation boundary
The primary mouse research used P021 in diet or maternal exposure, not a standardized human syringe formulation. A generic vial calculator would misrepresent the investigated route and outcomes.